Factors for failure of ultrasound-guided compression repair for femoral pseudoaneurysms after neuroendovascular therapy.


Journal

The neuroradiology journal
ISSN: 2385-1996
Titre abrégé: Neuroradiol J
Pays: United States
ID NLM: 101295103

Informations de publication

Date de publication:
Dec 2023
Historique:
pmc-release: 01 12 2024
medline: 15 11 2023
pubmed: 20 5 2023
entrez: 20 5 2023
Statut: ppublish

Résumé

Pseudoaneurysms are a serious complication of neuroendovascular therapy with femoral artery puncture, for which ultrasound-guided compression repair (UGCR) is often the first choice of radical therapy. We sought to retrospectively investigate the factors for failure of UGCR for pseudoaneurysm at the femoral artery puncture site. Among patients undergoing neuroendovascular therapy with femoral artery puncture at our hospital between January 2018 and April 2021, those who received a diagnosis of pseudoaneurysm and underwent UGCR were enrolled. They were classified into two groups according to whether UGCR was successful (UGCR group) or was converted to surgical repair (SR group). Patient and procedural characteristics were compared between the two groups. During the study period, 577 patients underwent neuroendovascular therapy with femoral artery puncture, 10 of whom (1.7%) received a diagnosis of pseudoaneurysm and underwent UGCR. There were seven patients in the UGCR group and three patients in the SR group. The sheath diameter tended to be larger in the SR group than in the UGCR group ( Physical activity may be associated with failure of UGCR. In patients with high physical activity, the use of sedatives and analgesics to keep them at rest during puncture site compression after UGCR may lead to successful UGCR.

Identifiants

pubmed: 37209101
doi: 10.1177/19714009231177382
pmc: PMC10649531
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

680-685

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

SAGE Open Med. 2019 Apr 16;7:2050312119843705
pubmed: 31019697
Int J Surg. 2008 Jun;6(3):214-9
pubmed: 18455971
Int J Cardiol. 2010 May 14;141(1):75-80
pubmed: 19095321
Clin Radiol. 2008 Dec;63(12):1310-6
pubmed: 18996260
J Am Coll Cardiol. 1997 Sep;30(3):670-5
pubmed: 9283524
World Neurosurg. 2018 Mar;111:e850-e855
pubmed: 29325953
Neurosurg Focus. 2021 Jul;51(1):E3
pubmed: 34198250
J Vasc Surg. 1997 May;25(5):803-8; discussion 808-9
pubmed: 9152307
J Vasc Interv Radiol. 2003 Jun;14(6):697-710
pubmed: 12817037
AJR Am J Roentgenol. 1999 Dec;173(6):1567-73
pubmed: 10584803
J Neuroendovasc Ther. 2020;14(2):48-55
pubmed: 37502456
Eur J Vasc Endovasc Surg. 2016 Jun;51(6):815-23
pubmed: 27026390
Radiology. 1991 Mar;178(3):671-5
pubmed: 1994400
J Vasc Surg. 2014 Nov;60(5):1359-1366
pubmed: 25175631
Acta Neurochir (Wien). 2017 Dec;159(12):2331-2335
pubmed: 28831587
Radiology. 1995 Feb;194(2):307-11
pubmed: 7824703

Auteurs

Hidenobu Hata (H)

Department of Neurosurgery, Kurashiki Central Hospital, Kurashiki, Japan.

Hiroyuki Ikeda (H)

Department of Neurosurgery, Kurashiki Central Hospital, Kurashiki, Japan.

Ryota Ishibashi (R)

Department of Neurosurgery, Kurashiki Central Hospital, Kurashiki, Japan.
Department of Neurosurgery, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka, Japan.

Ryosuke Kaneko (R)

Department of Neurosurgery, Kurashiki Central Hospital, Kurashiki, Japan.

Toshio Fujiwara (T)

Department of Neurosurgery, Kurashiki Central Hospital, Kurashiki, Japan.

Minami Uezato (M)

Department of Neurosurgery, Kurashiki Central Hospital, Kurashiki, Japan.

Masanori Kinosada (M)

Department of Neurosurgery, Kurashiki Central Hospital, Kurashiki, Japan.

Yoshitaka Kurosaki (Y)

Department of Neurosurgery, Kurashiki Central Hospital, Kurashiki, Japan.

Masaki Chin (M)

Department of Neurosurgery, Kurashiki Central Hospital, Kurashiki, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH